Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celltech Metadate CD Shows Morning/Afternoon Control Of ADHD, Label Says

Executive Summary

Celltech Metadate CD given once daily demonstrates control of attention deficit hyperactivity disorder early and late in the school day, product labeling notes.

You may also be interested in...



Ritalin LA Will Be Novartis’ Second Marketed Once-Daily Methylphenidate

Novartis' Ritalin LA will be the company's second once-daily methylphenidate formulation on the market

Ritalin LA Will Be Novartis’ Second Marketed Once-Daily Methylphenidate

Novartis' Ritalin LA will be the company's second once-daily methylphenidate formulation on the market

Alza Concerta Climbs To 15% Of ADHD Market With 170,000 Patients

Alza Concerta holds 15% of the attention deficit hyperactive disorder market, Senior VP-Sales & Marketing Dan Swisher told the company's annual analyst meeting in New York City Feb. 27.

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel